Mason Street Advisors, LLC Meridian Bioscience Inc Transaction History

Mason Street Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $317,404 - $480,123	-16,063 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $283 - $389	-18 Reduced 0.11%	16,063 $300,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $9,360 - $27,808	1,194 Added 8.02%	16,081 $375,000
Q4 2019 Feb 19, 2020	BUY	$7.9 - $10.14 $3,033 - $3,893	384 Added 2.65%	14,887 $145,000
Q3 2019 Nov 05, 2019	BUY	$9.17 - $12.01 $2,512 - $3,290	274 Added 1.93%	14,503 $138,000
Q2 2019 Aug 12, 2019	BUY	$10.88 - $17.6 $6,343 - $10,260	583 Added 4.27%	14,229 $169,000
Q1 2019 May 07, 2019	BUY	$15.51 - $17.61 $7,413 - $8,417	478 Added 3.63%	13,646 $240,000
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $8,799 - $11,950	606 Added 4.82%	13,168 $229,000
Q3 2018 Nov 13, 2018	BUY	$14.85 - $16.35 $4,959 - $5,460	334 Added 2.73%	12,562 $187,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $6,775 - $8,248	491 Added 4.18%	12,228 $194,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $10,488 - $12,312	760 Added 6.92%	11,737 $167,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $3,902 - $4,550	288 Added 2.69%	10,977 $154,000
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $143,767 - $153,387	10,689	10,689 $153,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.